Acer Therapeutics Inc
ACER
ACER was delisted on the 8th of November, 2023.
27 hedge funds and large institutions have $5.53M invested in Acer Therapeutics Inc in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 12 reducing their positions, and 10 closing their positions.
19% less capital invested
Capital invested by funds: $6.86M → $5.53M (-$1.33M)
21% less funds holding
Funds holding: 34 → 27 (-7)
67% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 12
70% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$296K |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$266K |
| 3 |
Two Sigma Advisers
New York
|
+$37.5K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$2.63K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$646 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$236K |
| 2 |
Barclays
London,
United Kingdom
|
-$126K |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$91.9K |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$83K |
| 5 |
Jane Street
New York
|
-$64K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Bank of America
Charlotte,
North Carolina
| – | -$11.6K | -3,580 | -100% |
|
27
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$5K | -1,500 | Closed |
|
28
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$5K | -1,331 | Closed |
|
|
BCA
29
Berman Capital Advisors
Atlanta,
Georgia
| – | -$3K | -1,093 | Closed |
|
|
PCM
30
Prelude Capital Management
New York
| – | -$3K | -821 | Closed |
|
31
Wells Fargo
San Francisco,
California
| – | -$278 | -86 | -75% |
|
32
UBS Group
Zurich,
Switzerland
| – | +$48 | +15 | +136% |
|
|
HS
33
Horan Securities
Cincinnati,
United States
| – | +$78 | +24 | New |
|
ACER Hedge Fund Activity: Q3 2020 in Review
27 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Acer Therapeutics Inc (ACER) for Q3 2020, worth a combined $5.53M — down 19% from $6.86M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of ACER and 3 opened new positions — a net loss of 7 holders — while 12 trimmed existing stakes and 4 added.
The largest buyer was Worth Venture Partners, adding an estimated $296K. The largest seller was BlackRock, cutting an estimated $236K.
- 27 institutional investors held Acer Therapeutics Inc (ACER) as of Q3 2020, down from 34 in Q2 2020.
- Funds reported $5.53M of Acer Therapeutics Inc stock for Q3 2020, down 19% quarter-over-quarter.
- 3 funds opened new Acer Therapeutics Inc positions in Q3 2020 and 10 closed out, a net change of -7 holders.
- The largest Acer Therapeutics Inc buyer in Q3 2020 was Worth Venture Partners, an estimated $296K added.
- The largest Acer Therapeutics Inc seller in Q3 2020 was BlackRock, an estimated $236K sold.
Based on aggregated 13F filings for Q3 2020.